2-acetylaminofluorene has been researched along with Sarcoma in 2 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
Sarcoma: A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| POIRIER, MM | 1 |
| MILLER, JA | 1 |
| MILLER, EC | 1 |
| DONIACH, I | 1 |
2 other studies available for 2-acetylaminofluorene and Sarcoma
| Article | Year |
|---|---|
THE CARCINOGENIC ACTIVITIES OF N-HYDROXY-2-ACETYLAMINOFLUORENE AND ITS METAL CHELATES AS A FUNCTION OF RETENTION AT THE INJECTION SITE.
Topics: 2-Acetylaminofluorene; Animals; Carcinogens; Chelating Agents; Cobalt; Copper; Fluorenes; Iron; Mamm | 1965 |
The effect of radioactive iodine alone and in combination with methylthiouracil and acetylaminofluorene upon tumour production in the rat's thyroid gland.
Topics: 2-Acetylaminofluorene; Adenoma; Iodine; Iodine Compounds; Lymphoma, Non-Hodgkin; Methylthiouracil; N | 1950 |